metronidazole and azithromycin
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Bacterial Vaginosis
Conditions
Bacterial Vaginosis
Trial Timeline
Jul 1, 2002 → May 1, 2006
NCT ID
NCT00324818About metronidazole and azithromycin
metronidazole and azithromycin is a approved stage product being developed by Pfizer for Bacterial Vaginosis. The current trial status is completed. This product is registered under clinical trial identifier NCT00324818. Target conditions include Bacterial Vaginosis.
What happened to similar drugs?
5 of 20 similar drugs in Bacterial Vaginosis were approved
Approved (5) Terminated (2) Active (14)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00324818 | Approved | Completed |
Competing Products
20 competing products in Bacterial Vaginosis